Apiam Animal Health Limited (ASX:AHX) today announced a market update ahead of the release of its financial results for the year ended 30 June 2023 (FY23).

Apiam Animal Health Limited (ASX:AHX) Managing Director Dr. Chris Richards outlines the Apiam brand and growing business, with veterinary practices joining the Apiam brand.

Apiam Animal Health Limited (ASX:AHX) is pleased to release its full year results for the 6-months to 31 December 2022 (H1 FY23).

Apiam Animal Health Limited (ASX:AHX) will release its financial results for the six months ended 31 December 2022 on Friday 24 February 2023.

Apiam Animal Health Ltd (ASX:AHX) MD Dr. Chris Richards speaks with ABN Newswire on the recent acquisitions the company has made in the mixed animal veterinary industry.

Apiam Animal Health Limited (ASX:AHX) is pleased to announce the acquisition of two mixed animal veterinary businesses in strategic NSW regions (the Acquisitions), for total consideration of $11.2 million.

American Medical Association approves CPT PLA code for PromarkerD predictive test for diabetic kidney disease

Apiam Animal Health Limited (ASX:AHX) is pleased to announce that it has completed the settlement of Hunter Equine Centre Pty Ltd (Hunter Equine Centre, HEC), a dedicated equine veterinary business located in the Upper Hunter Valley region of NSW.

Apiam Animal Health Limited (ASX:AHX) is pleased to announce the acquisition of Hunter Equine Centre Pty Ltd (Hunter Equine Centre (HEC), the Acquisition), a dedicated equine veterinary business located in the Upper Hunter Valley region of NSW.

Apiam Animal Health Limited (ASX:AHX) has expanded in Western Australia, via the acquisition of Harradine & Associates announced last week.